URight Hemoglobin A1c system, FORA A1c System
Assay, Glycosylated Hemoglobin. 510(k) K142664, from Taidoc Technology Corporation (New Taipei City, TW). Product code LCP, class 2.
As of Nov 19, 2026, K142664 is an FDA 510(k) held by Taidoc Technology Corporation, substantially equivalent on Jan 29, 2016 after 498 days, with no recalls tied to it in FDA's recall database.
- Review time: 498 days
- Recalls: 0
The URight Hemoglobin A1c System is intended to quantitatively measure the percent of hemoglobin A1c in capillary finger-stick or venous whole blood collected in EDTA (K2 and K3) or sodium heparin for clinical laboratory and point of care use. The measurement of hemoglobin A1c concentration is for use in monitoring long-term glucose control of persons with diabetes.
- Dca Vantage, Model 5075K071466 · Siemens Medical Solutions Diagnostics · Oct 9, 2007
- Hemoglobin A1C Reagent SetK031539 · Pointe Scientific, Inc., · Aug 6, 2003
- Q-Pad Test SystemK231465 · Qurasense · Dec 6, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 18, 2014
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7470
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files